Orladeyo - NDC Database

6 records found

Page:1

72769-101 Dec 04, 2020
Orladeyo 150 mg Oral Capsule by Biocryst Pharmaceuticals Inc.

72769-102 Dec 04, 2020
Orladeyo 110 mg Oral Capsule by Biocryst Pharmaceuticals Inc.

72769-111 Dec 04, 2020
Orladeyo 72 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.

72769-112 Dec 04, 2020
Orladeyo 96 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.

72769-113 Dec 04, 2020
Orladeyo 108 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.

72769-114 Dec 04, 2020
Orladeyo 132 mg Oral Pellet by Biocryst Pharmaceuticals, Inc.

Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.